Ebola Outbreak Over in Uganda
Centers for Disease Control and Prevention
As of January 11, the Ebola outbreak in Uganda has ended and entry screening to the US will be lifted
Ebola
Ebola Vaccine Regimens Safe, Immunogenic in Adults and Children
National Institutes of Health
The vaccine produced an antibody response beginning at 14 days post the first vaccination
Targeting the Deadly Coils of Ebola
University of Texas at Austin
A new study found that Ebola virus is stabilized by electrostatic interactions, which could lead to new treatments
New Universal Ebola Vaccine May Protect Against 4 Virus Types
Cincinnati Children's Hospital Medical Center
Early preclinical tests in lab models are encouraging
Four Countries in the African Region License Vaccine in Milestone for Ebola Prevention
World Health Organization
The licensing of the vaccine means that the manufacturer can stockpile and widely distribute this vaccine to African countries at risk of Ebola virus disease outbreaks
New Method Predicts Individual Response to Ebola Infection
Columbia University Mailman School of Public Health
In recent work with laboratory mice, researchers identify differences in immune response among mice who recovered from Ebola and those who perished
Investigational Monoclonal Antibody to Treat Ebola Is Safe in Adults
Today's Clinical Lab
Early-stage trial results show promise
Rare Antibodies Show Scientists How to Neutralize the Many Types of Ebola
The Scripps Research Institute
Two new studies are bringing Ebola virus's weaknesses into the spotlight
